drugset / Trial / NCT07796191

Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects

NCT07796191 ↗

Phase 1 Not yet recruiting 84 enrolled Jiangsu vcare pharmaceutical technology co., LTD
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study includes three groups of Drug-Drug Interaction( DDI ) studies: 1. To evaluate the effect of verapamil on the pharmacokinetics of a single oral dose of VC005 in healthy subjects; 2. To evaluate the effect of probenecid on the pharmacokinetics of a single oral dose of VC005 in healthy subjects; 3. To evaluate the effect of VC005 on the pharmacokinetics of a single oral dose of metformin tablets in healthy subjects.

Timeline

Start
2026-09-20
Primary completion
2026-11-30
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — —
Subject Probenecid Small molecule — —
Subject VC005 Unknown — —
Subject Verapamil Other / unclassified — —

Indications

No indication recorded.